As many as half of patients with superficial bladder cancer do not respond to the standard first-line chemotherapy placed into the bladder, according to current multi-center outcomes data. When this happens, typically, their only option is surgical removal of the bladder. Now, researchers at the Herbert Irving Comprehensive Cancer Center of NewYork-Presbyterian Hospital and Columbia University Medical Center are investigating an FDA-approved metastatic breast-cancer drug called Abraxane® that may prove a safe and effective alternative to surgery for these patients.

A leader in recent research on the interaction of genes and environment in the development of psychiatric illness, Avshalom Caspi, Ph.D. of King's College London, has been awarded the Mortimer D. Sackler, M.D., Prize for Distinguished Achievement in Developmental Psychobiology. Presented jointly by the Sackler Institute for Development Psychobiology at Columbia University Medical Center and the Sackler Institute for Developmental Psychobiology at Weill Cornell Medical College, the $60,000 award honors the 90th birthday of Dr. Sackler, and was established through gifts by his seven children.

Physician-scientists from NewYork-Presbyterian Hospital/Columbia University Medical Center will present their latest research findings at the American Society of Clinical Oncology Annual Meeting in Chicago, May 30 to June 3.

As many as one quarter of HIV patients have drug resistance, limiting their treatment options and raising their risk for AIDS and death. Now, maraviroc, the first of a new class of HIV drugs called CCR5 receptor antagonists, has been shown to be effective over 48 weeks for drug-resistant patients with R5 HIV-1, a variation of the virus found in more than half of HIV-infected patients.

The Lang Youth Medical Program for middle and high school students — the only hospital-based medical mentoring program of its kind in New York City — will welcome this year's class of students, who will be honored in a special white-coat ceremony, and celebrate the accomplishments of its first class of graduating seniors. The Oct. 29 event will be held at 6 p.m. at Morgan Stanley Children’s Hospital of NewYork-Presbyterian.

NewYork-Presbyterian Hospital is the top academic medical center in the nation for employee engagement — including job satisfaction, concern for patient care and effective communication — according to a new survey by HR Solutions Inc., a Chicago-based consulting firm.

The fifth leading cause of cancer in the United States, lymphoma is made up of more than 40 rare and highly diverse diseases that target the body's lymphatic system. Lymphomas include both one of the fastest growing cancers — Burkitt's lymphoma, which can double in size in as little as a day — and one of the slowest, chronic lymphocytic leukemia (CLL).

Phase I results of the first clinical trial of gene therapy for patients with advanced heart failure show the approach to be promising, with improvements in several measures of the condition's severity.